211 related articles for article (PubMed ID: 36002805)
1. Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Puyén ZM; Santos-Lázaro D; Vigo AN; Coronel J; Alarcón MJ; Cotrina VV; Moore DAJ
BMC Infect Dis; 2022 Aug; 22(1):705. PubMed ID: 36002805
[TBL] [Abstract][Full Text] [Related]
2. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
[TBL] [Abstract][Full Text] [Related]
3. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
[TBL] [Abstract][Full Text] [Related]
4. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
Ceyhan İ; Vezir S
Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
[TBL] [Abstract][Full Text] [Related]
5. A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
J Clin Microbiol; 2016 Dec; 54(12):2963-2968. PubMed ID: 27654338
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods].
Varıcı Balcı FK; Çavuşoğlu C
Mikrobiyol Bul; 2018 Apr; 52(2):123-134. PubMed ID: 29933730
[TBL] [Abstract][Full Text] [Related]
7. Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
Wu SH; Xiao YX; Hsiao HC; Jou R
Microbiol Spectr; 2022 Dec; 10(6):e0260522. PubMed ID: 36255328
[TBL] [Abstract][Full Text] [Related]
8. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs.
Lee J; Armstrong DT; Ssengooba W; Park JA; Yu Y; Mumbowa F; Namaganda C; Mboowa G; Nakayita G; Armakovitch S; Chien G; Cho SN; Via LE; Barry CE; Ellner JJ; Alland D; Dorman SE; Joloba ML
Antimicrob Agents Chemother; 2014; 58(1):11-8. PubMed ID: 24100497
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai.
Zade A; Shah S; Hirani N; Kondabagil K; Joshi A; Chatterjee A
J Glob Antimicrob Resist; 2022 Dec; 31():256-262. PubMed ID: 36272707
[TBL] [Abstract][Full Text] [Related]
10. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W
Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
[TBL] [Abstract][Full Text] [Related]
12. Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective
Kaniga K; Hasan R; Jou R; Vasiliauskienė E; Chuchottaworn C; Ismail N; Metchock B; Miliauskas S; Viet Nhung N; Rodrigues C; Shin S; Simsek H; Smithtikarn S; Ngoc ALT; Boonyasopun J; Kazi M; Kim S; Kamolwat P; Musteikiene G; Sacopon CA; Tahseen S; Vasiliauskaitė L; Wu MH; Vally Omar S
J Clin Microbiol; 2022 Jan; 60(1):e0291920. PubMed ID: 34705538
[TBL] [Abstract][Full Text] [Related]
13. Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
Mpagama SG; Houpt ER; Stroup S; Kumburu H; Gratz J; Kibiki GS; Heysell SK
BMC Infect Dis; 2013 Sep; 13():432. PubMed ID: 24034230
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
[TBL] [Abstract][Full Text] [Related]
15. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
[TBL] [Abstract][Full Text] [Related]
16. Use of Whole-Genome Sequencing to Predict
Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
[TBL] [Abstract][Full Text] [Related]
17. Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.
Rancoita PMV; Cugnata F; Gibertoni Cruz AL; Borroni E; Hoosdally SJ; Walker TM; Grazian C; Davies TJ; Peto TEA; Crook DW; Fowler PW; Cirillo DM;
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941636
[TBL] [Abstract][Full Text] [Related]
18. Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.
Bakuła Z; Modrzejewska M; Pennings L; Proboszcz M; Safianowska A; Bielecki J; van Ingen J; Jagielski T
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437627
[TBL] [Abstract][Full Text] [Related]
19. Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
Ssengooba W; Nakayita G; Namaganda CC; Joloba ML
PLoS One; 2018; 13(6):e0199638. PubMed ID: 29953491
[TBL] [Abstract][Full Text] [Related]
20. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
